Conjugated, rigidified bibenzimidazole ancillary ligands for enhanced photoluminescence quantum yields of orange/red-emitting iridium(III) complexes by Henwood, Adam F. et al.
 1 
Conjugated, Rigidified Bibenzimidazole Ancillary 
Ligands for Enhanced Photoluminescence 
Quantum Yields of Orange/Red-Emitting 
Iridium(III) Complexes 
Adam F. Henwood,a‡ Daniel Antón-García,a‡ Mégane Morin,a Diego Rota Martir,a David B. 
Cordes,a Colin Casey, a Alexandra M. Z. Slawin,a Tomas Lebl,a Michael Bühl,a and  
Eli Zysman-Colmana* 
a Organic Semiconductor Centre, EaStCHEM School of Chemistry, University of St Andrews, 
St Andrews, Fife, KY16 9ST, UK, Fax: +44-1334 463808; Tel: +44-1334 463826;  
E-mail: eli.zysman-colman@st-andrews.ac.uk; 
URL: http://www.zysman-colman.com 
 
‡ These authors contributed equally 
Abstract. A series of six novel [Ir(C^N)2(N^N)](PF6) complexes (C^N is one of two 
cyclometalating ligands: 2-phenyl-4-(2,4,6-trimethylphenyl)pyridine, MesppyH, or 2-
(napthalen-1-yl)-4-(2,4,6-trimethylphenyl)pyridine, MesnpyH; N^N denotes one of four 
neutral diamine ligands: 4,4’-di-tert-butyl-2,2’-bipyridine, dtbubpy, 1H,1’H-2,2’-
bibenzimiazole, H2bibenz, 1,1’-(a,a’-o-xylylene)-2,2’-bibenzimidazole, o-Xylbibenz or 2,2’-
biquinoline, biq) were synthesised and their structural, electrochemical and photophysical 
properties comprehensively characterised. The more conjugated MesnpyH ligands confer a 
red-shift in the emission compared to MesppyH but maintain high photoluminescence quantum 
yields due to the steric bulk of the mesityl groups. The H2bibenz and o-Xylbibenz ligands are 
 2 
shown to be electronically indistinct to dtbubpy but give complexes with higher quantum yields 
than analogous complexes bearing dtbubpy. In particular, the rigidity of the o-Xylbibenz 
ligand, combined with the steric bulk of the MesnpyH C^N ligands, give a red-emitting 
complex 4 (lPL = 586, 623 nm) with a very high photoluminescence quantum yield (FPL = 
44%) for an emitter in that regime of the visible spectrum. These results suggest that employing 
these ligands is a viable strategy for designing more efficient orange-red emitters for use in a 
variety of photophysical applications. 
Introduction.  
Phosphorescent emission of transition metal complexes, such as those of Ir(III),1 Ru(II),2 and 
Os(II)3 complexes, among others, has been a widely studied phenomenon in part because of 
the plethora of applications that are underpinned by this, but also because of the fundamental 
interest of chemists in studying molecules that emit light. Indeed, it is often such fundamental 
studies that inform the eventual applications of these complexes. Among the biggest challenges 
that remain for photoactive Ir(III) complexes are optimizing the photophysical properties of 
analogs that can emit in either the deep blue or deep red/near IR regions of the electromagnetic 
spectrum. 
 
For blue emitters, efficient quenching mechanisms begin to dominate as the HOMO-LUMO 
energy gap becomes large due to thermal population of non-emissive triplet metal centred 
(3MC) states,4 which leads to much a larger non-radiative rate constant (knr). In addition, the 
excited states of blue-emitting iridium(III) complexes tend to be ligand centred (LC) in nature, 
and thus they phosphoresce with a relatively attenuated spin-orbit coupling (SOC) mechanism, 
resulting in smaller radiative rate constants (kr) than complexes that emit from a triplet metal-
to-ligand charge transfer (3MLCT) state. Failure to largely overcome this problem for blue 
emitters has limited the power efficiency of electroluminescent devices such as organic light-
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emitting diodes (OLEDs)5 and light-emitting electrochemical cells (LEECs)6 based on these 
materials. 
 
For red emitters, the energy gap law becomes increasingly problematic,7 due to the inverse 
relationship between the non-radiative rate constant (knr) and emission energy,8 and the cubic 
dependence on the emission energy of the radiative rate constant (kr).8-9 Thus, in the case of 
low energy emitters there is expected to be a simultaneous decrease in kr and increase in knr. In 
particular, the enhancement in knr is facilitated by progressively more probable Franck-Condon 
coupling of T1 vibrational modes with high lying S0 vibrational modes.10 Thus, red-emitting 
OLEDs do not show the same level of efficiencies as green and yellow devices.11 In addition 
to devices, red emitters are highly desirable for use in biological applications such as 
bioimaging12 and photodynamic therapy,13 due to the high transmittance of red/IR photons 
through biological media. Thus, there is considerable interest in developing red-emitting 
complexes with high quantum yields.  
 
Recently, our group has explored design strategies to achieve high photoluminescence 
quantum yields (FPL) for cationic Ir(III) complexes of the form [Ir(C^N)2(N^N)]+ (C^N here 
denotes a bidentate anionic cyclometalating ligand exemplified by the 2-phenylpyridine, ppyH, 
ligand while N^N is a neutral bidentate diimine ligand such as 2,2’-bipyridine, bpy). We have 
particularly focussed on addressing the aforementioned challenges related to blue emitters,14 
and have demonstrated that a combination of rigid and sterically bulky ligand chelates 
effectively suppress intra- and intermolecular contributions to the non-radiative rate constant 
(knr), leading to FPL values of blue- and green-emitting cationic [Ir(C^N)2(N^N)]+ complexes 
in both MeCN solution and doped thin films that approach unity. Specifically, we found that 
replacing the prototypical N^N ligand 4,4’-di-tert-butyl-2,2’-bipyridine (dtbubpy) with a 
 4 
modified biimidazole N^N ligand containing a rigid tethering unit (1,1’-(a,a’-o-xylylene)-
2,2’-biimidazole, o-Xylbiim) restricted conformational motion of the chelate in both the ground 
and excited states, suppressing these deleterious intramolecular non-radiative decay 
pathways.14e The rational ancillary ligand design was combined with modification of an 
archetypal C^N ligand (2,4-difluorophenylpyridine, dFppyH) with a bulkier analogue (2-(2,4-
difluorophenyl)-4-mesitylpyridine, dFMesppy) to suppress intermolecular quenching, leading 
to a photoluminescence quantum yield of 90% in MeCN solution (Chart 1).14h   
 
Chart 1. Previously studied complexes modified to achieve high photoluminescence quantum 
yields.14h 
Given the efficacy of the o-Xylbiim ligand in reducing vibrational contributions to knr for 
blue emitters, we thus considered whether this rigid ligand motif could be employed as a 
universal design strategy for emitters across the visible spectrum. In particular, we wished to 
see if this could be applied to suppressing the coupling of the excited state to non-emissive 
Franck-Condon vibronic modes that quench the emission of red-emitters. 
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Several strategies4 can be employed to red-shift the emission in cationic iridium complexes, 
which include (but are not limited to): (1) destabilising the energy of the HOMO (typically 
localised on the metal and C^N ligands) and/or stabilising the energy of the LUMO (typically 
localised on the N^N ligands) with appropriate electron-donating15 and/or accepting16 
functionalities; (2) inducing excimer-based emission;11b (3) extending the effective conjugation 
length of the ligands.17 In this study, we explore conjugated analogues of our previously 
reported biimidazole ligands: 1H,1’H-2,2’-bibenzimiazole (H2bibenz) and its xylylated 
derivative (1,1’-(a,a’-o-xylylene)-2,2’-bibenzimidazole, o-Xylbibenz). The extended 
conjugation present in the bibenzimidazole core was expected to promote a red-shifted 
emission compared to the previously studied biimidazole complexes, while it was anticipated 
that application of our rigid tethering strategy here would effectively mitigate contributions to 
knr, thereby leading to emitters showing higher FPL. 
 
To evaluate this emitter design, six new cationic iridium complexes were synthesized (Chart 
2). Complexes 1 and 2 utilise our previously reported 2-phenyl-4-(2,4,6-
trimethylphenyl)pyridine (MesppyH) C^N ligand.18 Cationic iridium complexes bearing bulky 
ligands have been explored in the literature,19 and indeed this ligand, and fluorinated analogues 
bearing the mesityl group installed at the 4-position of the coordinating pyridine ring,14h, 14m, 20 
have been shown to be effective at improving: (1) the solubility of the complex in organic 
solvents such as DCM and MeCN, which is important for producing films with a homogeneous 
morphology in the solution-processed devices; and (2) impeding intermolecular processes from 
occurring resulting in diminished non-radiative decay as a function of the steric bulk of the 
mesityl rings. Complexes 1 and 2 differ in the nature of the bibenzimidazole ligand. For 1, the 
distal nitrogen atoms are protonated (H2bibenz) while for 2 there is the xylylene tether (o-
Xylbibenz). Complexes 3 and 4 possess a more conjugated C^N ligand (2-(napthalen-1-yl)-4-
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(2,4,6-trimethylphenyl)pyridine, MesnpyH) in order to promote a further red-shift in the 
emission as a function of HOMO destabilization. In addition to these four complexes, we have 
also synthesized two reference complexes employing the MesnpyH C^N ligand: complex 5, 
which contains the much employed 4,4’-di-tert-butyl-2,2’-bipyridine (dtbubpy) N^N ligand 
and complex 6, employing the highly conjugated 2,2’-biquinoline (biq) ligand, which had 
previously been used to produce deep red-emitting cationic iridium complexes in combination 
with C^N ligands such as ppyH21 and 1-phenylpyrazole (ppzH).22  
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Chart 2. Complexes reported in this study. 
 
Results and Discussion. 
Synthesis. 
The ligand syntheses are outlined in Scheme 1. The N^N ligand H2bibenz was synthesised 
in two steps in excellent yield from o-nitroaniline, which was first reduced using SnCl2 to give 
the diamine (95%) and subsequently condensed with 2,2,2,-trichloroacetimidate (92%).23 o-
Xylbibenz was obtained in good yield by alkylation of H2bibenz with a,a’-dibromo-o-xylene 
in MeCN (60%), under analogous conditions to our previous report.14e The C^N ligands were 
obtained through a sequential set of Suzuki-Miyaura cross-coupling reactions using a 
previously reported strategy (MesppyH = 96% and MesnpyH = 68%).18b, 18c  
 
Scheme 1. Synthesis of organic intermediates and ligands. a SnCl2 (3.6 equiv.), EtOH, HCl, 
60 °C, 16 h, N2. b i) MeOH, HCl, 0 °C, 3 h, N2 ii) K2CO3 (1.0 equiv.), rt, 39 h, N2. c MeCN, 
NaOH(aq) (5.6 equiv.), 80 °C, 19 h, N2. d Pd(PPh3)4 (5 mol%), K2CO3 (2.8 equiv.), 1,4-
dioxane/water (3:1 v/v), 100 °C, 19 h, N2. 
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The intermediate dichloro-bridged iridium dimers were synthesised using IrCl3.3H2O in the 
presence of excess C^N ligand in a refluxing mixture of 2-ethoxyethanol and water.24 The 
mononuclear iridium complexes were obtained by cleaving the [Ir(C^N2)(µ-Cl)]2 dimer with a 
small excess of N^N ligand in a refluxing solution of DCM/MeOH. Purification was carried 
out first by silica gel chromatography, then anion metathesis was achieved by precipitating 
concentrated MeOH solutions of the complexes from aqueous NH4PF6 solutions. The 
compounds were then recrystallised. Scheme 2 summarises reagents and conditions employed 
in the synthesis of complexes 1–6.  
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Scheme 2. Synthesis of 1–6. Reagents and conditions: a N^N ligand (2.2 equiv.), 
CH2Cl2/MeOH (1:1 v/v), reflux, 24 h, N2. 
 
Chemical and Structural Characterization. 
   All complexes, as well as the new C^N ligand MesnpyH, were fully characterised by 1H and 
13C NMR spectroscopy, high-resolution mass spectrometry (HRMS), melting point analysis, 
and elemental analysis (EA). Finally, the structure of the MesnpyH C^N ligand, as well as the 
structures of complexes 1 and 3–6 were unequivocally determined by single crystal X-ray 
diffraction analysis. 
 
   Previous studies on [Ir(dFppy)2(o-Xylbiim)](PF6) and [Ir(dFMesppy)2(o-Xylbiim)](PF6) 
displayed broad and featureless 1H NMR spectra, and additional signals indicative of multiple 
conformers in solution. The complexity of these 1H NMR spectra was attributed to 
diastereomeric atropisomerism, a consequence of the slow inversion kinetics of the o-Xylbiim 
between its two conformations, as well as slow rotation of the mesityl ring with respect to the 
pyridine in the case of [Ir(dFMesppy)2(o-Xylbiim)](PF6), coupled with the stereochemistry at 
iridium. Complex 2 (Figure 1), bearing the o-Xylbibenz ligand, shows a 1H NMR spectrum 
with relatively sharper signals at room temperature compared to complexes possessing the o-
Xylbiim ligand. However, very broad signals are apparent at around 6.3 and 6.9 ppm associated 
with the methylene resonances associated with the tethered xylylene in the o-Xylbibenz ligand, 
which indicate that conformational exchange is again slow on the NMR time scale. To better 
understand the conformational dynamics, the sample was heated in solutions of DMSO-d6 to 
372 K. Sharpening of broad signals with increasing temperature was observed and the AB spin 
system pattern of the methylene protons within the o-Xylbibenz ligand methylene group was 
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revealed in the region around 6.3 ppm. Therefore, we assume that the restricted dynamic is 
likely associated with the ring flipping between the two o-Xylbibenz conformations analogous 
to the one already described for complexes with the o-Xylbiim ligand.14e, 14h A similar 
assumption could be also made for complex 4 since, although the AB spin system pattern is 
less apparent, restricted conformational exchange affects signals in the same chemical shift 
regions (Figure 2).    
 
 
Figure 1. 1H NMR temperature study of complex 2 in DMSO-d6.   
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Figure 2. 1H NMR temperature study of complex 4 in DMSO-d6.   
   In contrast to the C^N ligands dFMesppy and Mesppy, which are viscous oils at room 
temperature, Mesnpy forms white crystals upon cooling, facilitated by p-p stacking of adjacent 
naphthalene rings (Figure 5), at centroid-to-centroid distances of 3.6146(11) and 3.7689(11) 
Å. As expected, the methyl groups on the mesityl ring induce a large torsional angle between 
the mesityl and pyridine rings [79.60(19)o]. Steric effects also induce a significant [43.2(2)o] 
torsional twist between the naphthalene and the pyridine rings.  
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Figure 5. X-ray crystal structures of Mesnpy viewed facing the pyridine (a) and the mesityl (b). 
Packing of Mesnpy (c) showing packing of adjacent dimers.   
   The crystal structures of 1 and 3–6 show the expected distorted octahedral geometries with 
the pyridyl nitrogen atoms of the C^N ligands in the usual trans configuration (Figure 6). 
Complexes 1 [H···F distances 1.875 – 2.157 Å, and corresponding N···F distances 2.81(2) – 
3.00(4) Å] and 3 [H···F distances 1.98(3) and 2.08(6) Å, and corresponding N···F distances 
2.858(5) and 2.949(6) Å] form tight hydrogen bonds between the -NH hydrogen atoms and the 
PF6- counteranion, similar to other complexes featuring H2biim14e, 25 and H2bibenz ligands.26 
All five structures show the mesityl groups adopting a highly twisted conformation with respect 
to the pyridine ring [torsions 66.1(4) – 86.2(3)°]. Furthermore, the distortion of the naphthalene 
ring with respect to the pyridine observed in the crystal structure of Mesnpy is also observed 
in the structures of 3–6. While there is essentially no torsional twist between the phenyl and 
pyridine rings of Mesppy in 1 [0(2) – 3(2)°], the analogous torsional distortions between phenyl 
and naphthyl rings of Mesnpy are all significantly larger for 3–6 [15.1(4) – 31.0(4)°], which is 
a result of the naphthalene rings minimising steric interactions with the pyridine rings. 
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Figure 6. X-ray crystal structures of complexes 1, 3, 4, 5 and 6. Solvent molecules and C-H 
hydrogen atoms have been removed for clarity. Counterions have been included to show 
hydrogen-bonding interactions observed for complexes 1 and 3, where hydrogen bonding 
interactions are shown with dotted lines. Such interactions are not present in the crystal 
structures of 4, 5 and 6. Thermal ellipsoids are drawn at the 50 % probability level. 
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Electrochemical Properties:  
   Cyclic voltammetry (CV) was carried out on 1–6 in deaerated MeCN in order to assess 
electrochemical reversibility and the energies associated with the oxidation and reduction 
waves. The ferrocene/ferrocenium redox couple was used as the internal standard, and the 
redox potentials are reported vs SCE. The CV traces are shown in Figure 7 while relevant 
electrochemical data are given in Table 1. 
 
Table 1. Relevant electrochemical data for complexes 1–6.a 
Complex Epa(ox) 
/ V  
Epc(ox) 
/ V  
DEp(ox) / 
mV 
Epc(red) 
/ V  
Epa(red) 
/ V  
DEp(red) 
/ mV 
DE / 
V b 
EHOMO / 
eV c 
ELUM
O / eV 
c 
1 1.33 f 1.21 f 120 -1.46 e - - 2.79 -5.53 -3.07 
2 1.35 f 1.26 f  90 -1.41 d -1.30 d 110 2.76 -5.57 -3.15 
3 1.25 d 1.17 d 80 -1.41 e - - 2.66 -5.50 -3.11 
4 1.18 d 1.09 d 90 -1.48 d -1.38 d 100 2.66 -5.43 -3.07 
5 1.26 d 1.16 d 100 -1.42 d -1.33 d 90 2.42 -5.50 -3.13 
6 1.11 e - - -1.11 d -1.03 d 80 2.22 -5.37 -3.49 
a in MeCN at a scan rate of 100 mV s-1 with Fc/Fc+ employed as an internal standard, and 
data reported vs SCE (Fc/Fc+ = +0.38 V in MeCN).27 b DE = Epa(ox) - Epc(red). c EHOMO/LUMO = 
-[Eonsetox/red vs Fc/Fc+ + 4.8] eV.28 d Reversible redox wave. e Irreversible redox wave. f Quasi-
reversible redox wave. 
 
   The oxidation potentials of the complexes are sensitive to the nature of the C^N ligands. The 
first oxidation waves of 1 and 2 (Epa(ox) = 1.33 V for 1 and 1.35 V for 2), bearing Mesppy C^N 
ligands, come at similar potentials, and are quasi-reversible, respectively, while the oxidation 
waves in 3 and 4 are reversible and shifted cathodically (Epa(ox) = 1.25 V for 3 and 1.18 V for 
4) due to the increased conjugation present in the Mesnpy C^N ligands. Our previously 
reported study on iridium complexes bearing functionalised biimidazole ligands showed that 
the oxidation potentials were sensitive to the nature of the biimidazole. For example, 
[Ir(dFppy)2(H2biim)](PF6) (E1/2(ox) = 1.51 V) is anodically shifted compared to [Ir(dFppy)2(o-
Xylbiim)](PF6) (E1/2(ox) = 1.44 V), and [Ir(dFMesppy)2(o-Xylbiim)](PF6) (E1/2(ox) = 1.37 V).14h 
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By contrast, the differences in oxidation potentials of the analogous complexes employing 
either H2bibenz or o-Xylbibenz as the N^N ligand are much smaller (cf. 1 vs 2 and 3 vs 4). 
When dtbubpy is used as the N^N ligand (5) there is almost no difference in the oxidation 
potential (Epa(ox) = 1.26 V) compared to its mesityl-free analogue [Ir(npy)2(dtbubpy)](PF6), 
where npy is 2-(napthalen-1-yl)pyridine (E1/2(ox) = 1.13 V).29 These results are consistent with 
the solid-state crystal structure data where the methyl groups on the mesityl ring force it into a 
mutually orthogonal conformation with respect to the pyridine ring and thus electronically 
decouple it from the system.  
 
   Finally, in contrast to the complexes 1–5, the oxidation of 6 is completely irreversible and is 
significantly cathodically shifted (Epa(ox) = 1.11 V). The lower oxidation potential of 6 
compared to [Ir(ppz)2(biq)](PF6) (where ppzH is 2-phenylpyrazole; E1/2(ox) = 1.42 V),22 and 
[Ir(ppy)2(biq)](PF6) (E1/2(ox) = 1.24 V)21 demonstrates the role played by the naphthyl ring in 
facilitating the oxidation process. 
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Figure 7. CV traces of complexes 1–6 in deaerated MeCN solution, reported versus SCE 
(Fc/Fc+ = 0.38 V in MeCN).27 Scan rates are at 100 mV s-1 and scans are in the positive 
direction.   
 
   From these data, which are in line with the literature,14h, 14k, 22, 30 and in accordance with the 
DFT computed ground state calculations (vide infra), the first oxidation waves of 1–6 can be 
ascribed to the IrIII/IrIV redox couple, coupled with contribution from the cyclometalating arene 
of the C^N ligands. This latter contribution to the oxidation is evidenced by the modestly 
anodically shifted oxidation potentials of 1 and 2 (Epa(ox) = 1.33–1.35 V), bearing Mesppy C^N 
ligands, compared to 3–6 (Epa(ox) = 1.11–1.26 V) which have more conjugated Mesnpy C^N 
ligands. 
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   The reduction potentials are much less sensitive to the nature of the C^N ligands, remaining 
largely unchanged for complexes 1–5 (Epc(red) = -1.39 to -1.45 V for 1–5). However, the 
reversibility of the reduction waves does appear to be ligand dependent. Complexes 1 and 3, 
bearing the H2bibenz N^N ligand, possess irreversible reduction waves, which suggest that the 
secondary amines are susceptible to electrochemical degradation processes upon reduction. 
Complexes 2 and 4, bearing the alkylated o-Xylbibenz analogue, show reversible reduction 
waves, indicating that such unfavourable degradation processes observed for complexes 1 and 
3 are blocked upon alkylation. The reduction of 5 is also reversible, which is a common feature 
of complexes bearing dtbubpy ligands. The reduction wave of 6 (Epc(red) = -1.11 V) is also 
reversible and is significantly anodically shifted compared with 1–5, as a result of the strong 
p-accepting character of the biq ligand. There are two important conclusions to draw from these 
results: 1) the reduction is predominantly an N^N-based process; a conclusion in line with the 
literature14h, 14k, 22, 30 and DFT calculations (vide infra); 2) it was previously shown that the 
electron-releasing properties of H2biim or o-Xylbiim N^N ligands destabilise the LUMO, and 
so complexes such as [Ir(dFMesppy)2(o-Xylbiim)](PF6) (DE = 3.36 V) have a much larger 
redox gap than analogous complexes bearing dtbubpy ligands, such as 
[Ir(dFMesppy)2(dtbubpy)](PF6) (DE = 2.95 V).14h However, in this work, this effect in 
complexes 1–4 is offset by the increased conjugation across the N^N ligand backbone seen in 
H2bibenz and o-Xylbibenz. This second point is evidenced by studying the net redox gaps of 
complexes 3–5, which are largely unchanged regardless of the N^N ligand (DE = 2.36–2.39 V 
for 3–5). Although the oxidation potentials complexes 3 and 5 (Epa(ox) = 1.25–1.26 V for 3 and 
5) are modestly anodically shifted compared to that of 4 (Epa(ox) = 1.18 V), this is compensated 
for by a similar anodic shift in the reduction potentials of 3 (Epc(red) = -1.41 V) and 5 (Epc(red) = 
-1.42 V) compared to 4 (Epc(red) = -1.48 V).  
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Figure 8. Variation of the frontier MO energies (in eV) as a function of the ligand environment 
(singlet ground states, B3LYP level); the five highest occupied and the file lowest unoccupied 
orbital levels are shown. In the centre, plots of the HOMOs (below) and LUMOs (above) are 
included (H atoms omitted for clarity, isodensity value 0.04 a.u.). 
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   Density functional theory (DFT) calculations (B3LYP on PBE0-optimized structures) largely 
corroborate the principal trends observed in the electrochemical data. A Kohn-Sham energy 
diagram of complexes 1–6, as well as the electron density distribution plots for the HOMOs 
and LUMOs, is shown in Figure 8. For each of the six complexes, the HOMO is comprised of 
almost equal contributions of iridium d-orbitals and cyclometalating aryl rings. The relative 
HOMO energies are predicted to be higher for complexes 3–6 than for 1 and 2 as a function of 
the increased conjugation of the Mesnpy C^N ligands. The principal theoretical deviation from 
the experimental data is that of the HOMO of complex 6; from the CV trace this complex has 
the least positive oxidation potential (Epa(ox) = 1.11 V) implying an oxidation process facilitated 
by a HOMO that is higher in energy than the other complexes in the series. By contrast, the 
DFT calculations predict a stabilisation in the HOMO energy of 6 relative to complexes 3–5. 
The LUMO is localised almost exclusively on the N^N ligands albeit with a small metal-based 
contribution. There is predicted to be very little variation in the LUMO energies of complexes 
1–5, which supports the experimental assertions that the electronic behaviour of dtbubpy, 
H2bibenz and o-Xylbibenz are largely indistinguishable. The large stabilization of the LUMO 
predicted for 6 corresponds well with the CV data. Even though there is no strict relation 
between MO energies and ionization potentials (IPs) or electron affinities (EAs) in DFT, the 
same trends are obtained in the actual computed vertical IPs and EAs (see Table S2 in the 
supporting information). 
 
 
UV-Vis Absorption. 
   The UV-vis absorption spectra for 1–6 are shown in Figure 9 and the molar absorptivity data 
are reported in Table 2. In the high-energy region of the spectrum (250–400 nm), p-p* 
transitions with high molar absorptivity dominate for all complexes. Among these, two distinct 
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sets of transitions can be identified: 250–300 nm and 300–400 nm. For complexes 1 and 2, a 
single distinct higher energy p-p* transition (labs = 263 nm for 1 and 270 nm for 2) is observed, 
along with poorly resolved shoulders (labs = 282 nm for 1 and 289 nm for 2). For complexes 3 
and 4, similar transitions (labs = 264 nm for 3 and 263 nm for 4) are accompanied by well-
resolved absorption bands (labs = 295 nm for 3 and 291 nm for 4) that are more highly 
absorptive and red-shifted compared to the corresponding shoulders present in 1 and 2. These 
absorption bands are therefore assigned to p-p* transitions on the cyclometalating ligands. 
Higher absorptivities are also observed for complexes bearing o-Xylbibenz (2 and 4) compared 
to H2bibenz (1 and 3), due to additional xylylene-centred p-p* transitions. The absorption 
spectrum of 5 shows a similar profile in the high energy region to those of 1–4 with a band at 
266 nm, along with two shoulders at 285 and 294 nm. For 6, the absorption spectrum in the 
high-energy region is dominated by a highly absorbing p-p* transition (labs = 265 nm), 
obscuring the naphthyl-localised shoulder (labs = 294 nm).  
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Figure 9. UV-vis absorption spectra of complexes 1–6 in MeCN. 
 
   In the region between 300–400 nm, each complex possesses two well-defined, highly 
absorptive bands. The bands in this region are assigned to p-p* transitions involving the N^N 
ligand, evidenced by the near identical absorption maxima between 1 and 3 for this pair of 
bands (labs = 322, 340 nm for 1 and 325, 339 nm for 3); it is worth noting the moderately 
increased molar absorptivity observed for 3 compared to 1. Similarly, these bands in 2 and 4 
coincide (labs = 335, 352 nm for 2 and 337, 351 nm for 4) and are more strongly resolved, 
bathochromically-shifted, and significantly more absorptive than the corresponding bands in 
complexes 1 and 3. The increased absorptivity observed for complexes 2 and 4 can be attributed 
to additional p-p* contributions from the xylylene bridge. The bands at 310 and 339 nm for 5 
are hypsochromically shifted compared to those present in 1–4, which are clustered between 
322–339 and 340–361 nm, respectively. The pair of bands observed for 6 at 354 and 370 nm 
is the most red-shifted due to the greater p-accepting character of the biq ligand.   
 
Table 2. Absorption maxima and their corresponding molar absorptivities, as well as the 
optical gap for complexes 1-6.a 
Complex labs / nm [e × 10-4 / M-1 cm-1] E0-0 / nm  
1 263 [3.60], 282(sh) [3.12], 322 [3.50], 340 [2.70], 361(sh) [1.86], 402 [0.55], 
431 [0.27], 449 [0.18], 479 [0.07] 
472 
2 270 [5.01], 289(sh) [3.31], 335 [3.77], 352 [4.01], 386(sh) [1.80], 425 [0.46], 
442 [0.28], 471 [0.12], 517 [0.02] 
500 
3 264 [3.60], 295 [3.45], 325 [3.17], 339 [3.10], 361(sh) [2.01], 436 [0.48], 463 
[0.41], 517 [0.02], 559 [0.01] 
538 
4 263 [5.63], 291 [4.60], 319(sh) [3.97], 337 [4.65], 351 [4.52], 374(sh) [2.40], 
391(sh) [1.52], 427 [0.82], 458 [0.71], 519 [0.04], 556 [0.01] 
534 
5 266 [5.64], 285(sh) [4.63], 294(sh) [4.19], 310 [3.23], 339 [2.20], 358(sh) 
[1.62], 391 [0.65], 422 [0.68], 454 [0.63], 517 [0.01], 555 [0.01] 
540 
6 265 [6.03], 294(sh) [3.43], 354 [2.49], 370 [2.22], 420 [0.68], 443(sh)[0.52], 
539 [0.07] 
550 
a Measurements carried out in aerated MeCN. E0-0 estimated from the intersection point of the 
absorption and emission spectra at 298 K in MeCN. 
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   The absorption bands beyond 450 nm are assigned to mixed charge-transfer (CT) transitions 
on the basis of their lower absorptivity values. Surprisingly, these transitions are insensitive to 
the nature of the N^N ligands and are strongly affected by the nature of the C^N ligand, 
implying an unusual metal-to-C^N ligand (MLCT) transition, distinct from the typical metal-
to-N^N ligand transitions generally associated with [Ir(C^N)2(N^N)]+ complexes.31 Consider 
the spectra of complexes 1 and 2 featuring the Mesppy C^N ligand. Both these spectra show 
poorly resolved shoulders (labs = 431 nm for 1 and 425 nm for 2) and a low intensity absorption 
band (labs = 449 nm for 1 and 442 nm for 2). This is contrasted with the spectra of the Mesnpy 
complexes 3–5, which exhibit red-shifted, highly absorptive, and well-resolved bands (labs = 
436, 463 nm for 3, 427, 458 nm for 4 and 422, 454 nm for 5). These spectra also contain a 
further red-shifted low intensity band at in the region of 555 nm (labs = 559 nm for 3, 556 nm 
for 4 and 555 nm for 5). Thus, the presence of the naphthyl rings in 3–5 results in enhanced 
and red-shifted absorption bands in the near-UV region, compared to 1 and 2. The absorption 
spectrum for 6 is distinct with only a single blue-shifted band at 443 nm. This, however, is 
coupled with a relatively strongly absorptive and broad band centred at 539 nm, tailing to ca. 
640 nm that is attributed to spin-forbidden mixed CT transitions. Similar transitions are present 
for complexes 1–5, but these are even less absorptive and have absorption onsets that are 
significantly blue-shifted (labs < 585 nm for the onset of absorption of 1–5). The general pattern 
of the absorption maxima in Table 2 is reasonably well reproduced, at least qualitatively, at the 
time-dependent DFT (TD-B3LYP) level (see Table S3 in the supporting information). Many 
dark states with zero or near-zero oscillator strength are predicted, but the transitions with 
significant oscillator strength tend to be close to the observed ones. In particular the trend in 
the observed lmax values is well mirrored in the TD-B3LYP data, as is the strongly red-shifted 
spin-forbidden CT transition for complex 6 (computed at 602 nm, Table S3). 
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Emission Spectroscopy. 
   The emission spectra measured in deaerated MeCN for 1–6 are shown in Figure 10 and the 
photophysical data are summarized in Table 3. TD-DFT calculations were undertaken to 
provide theoretical insight into the nature of the excited states and the computed spin density 
plots that describe the T1 state are given in Figure 11. Complex 1 is a green/yellow emitter (lPL 
= 500, 527 nm) with a narrow and somewhat structured emission profile. The short emission 
lifetime (tPL = 1.26 µs) coupled with a spin density distribution delocalized across the C^N and 
N^N ligands and the iridium centre, are indicative of a triplet excited state that is predominantly 
mixed ligand-to-ligand and metal-to-ligand charge transfer (3MLCT/3LLCT) in character. The 
structured emission profile suggests that there is also some ligand centred (3LC) contribution 
to the excited state. The emission of [Ir(ppy)2(H2bibenz)]PF6 has been reported previously in 
DCM and is red-shifted (FPL = 534 nm) compared to 1 and reported as unstructured in nature.32 
This can be attributed to the more polar nature of the MeCN solvent, which can form hydrogen-
bonds to the distal hydrogen atoms of the H2bibenz ligand,25a, 25c polarizing this bond and 
increasing the effective electron density on the H2bibenz ligand thereby leading to the blue-
shift in the emission due to destabilisation of the ancillary ligand-based orbitals. 
 
Table 3. Relevant solution state photophysical data for complexes 1–6.a 
Complex λPL / nm b FPL / % c tPL / µs d kr × 10-5 / s-1 knr × 10-5 / s-1 
1 500, 527 78 1.26 6.19 1.75 
2 560, 580 89 1.83 4.86 0.60 
3 585, 626 32 5.10 0.63 1.33 
4 586, 623  44 7.65 0.58 0.73 
5 580, 620 18 7.93 0.27 1.03 
6 670 <1 - - - 
a Measurements at 298 K in deaerated MeCN. b lexc = 420 nm. c [Ru(bpy)3]Cl2 
used as the reference (FPL = 4.0% in aerated water at 298 K).33 d lexc: 375 nm. 
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   Compared to 1, the emission profile of complex 2 is significantly red-shifted (lPL = 560, 580 
nm) and the excited state is moderately longer lived (tPL = 1.83µs). A similar trend is observed 
for the emission of complex [Ir(ppy)2(dMebibenz)](PF6) (where dMebibenz is 1,1’-dimethyl-
2,2’-bibenzimidazole; lPL = 560, 580 nm) in DCM, wherein the complex with the alkylated 
bibenzimidazole ligand displays red-shifted emission compared to the protonated analogue 
[Ir(ppy)2(H2bibenz)]PF6.32 By contrast, the opposite trend was observed between the 
complexes [Ir(dFppy)2(H2biim)](PF6) and [Ir(dFppy)2(o-Xylbiim)](PF6), where in the latter 
there was a small blue-shift in the emission as a function of a strongly 3LC-based emission.14e  
 
Figure 10. Normalised emission spectra for 1–6 in deaerated MeCN solution. lexc: 420 nm. 
Inset: MeCN solutions of 1–6 (from left to right) illuminated under UV (365 nm) irradiation.  
 
   The differences observed in the emission spectra of complexes 1 and 2 are surprisingly not 
mirrored in the analogous comparison between 3 and 4, which show virtually identical 
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emission spectra (lPL = 585, 626 nm for 3 and 586, 623 nm for 4). This change in behaviour 
suggests that the presence of the naphthyl ring within the C^N ligands induces greater 3LC 
character to the emissive triplet state, thereby making the emission of these complexes less 
sensitive to substitution on the ancillary ligand. The computed spin density distributions for 3 
and 4 (Figure 11) corroborate this assessment as they reveal a decidedly increased 3LC 
character of the T1 state of these two complexes compared to 1 and 2. Likewise, complex 5 
also emits from a 3LC state, exhibiting a very similar emission profile to those of 3 and 4 (lPL 
= 580, 620 nm for 5) and a spin density plot delocalised on the C^N ligand. These excited state 
characteristics mirror the ground state measurements carried out on 3–5, wherein the electronic 
effects of the H2bibenz, o-xylbibenz and dtbubpy are largely indistinct.  
 
The 3LC nature of the emission in complexes 3–5 appears to be typical of iridium complexes 
featuring cyclometalated naphthalene rings. For example, the archetypal [Ir(C^N)2(N^N)]+ 
complex, [Ir(ppy)2(dtbubpy)](PF6) exhibits a broad and structured 3MLCT/3LLCT emission in 
solution (lPL = 591 nm; FPL = 27%, tPL = 0.39 µs in MeCN).34 However, incorporation of the 
naphthalene ring within the C^N ligand framework of the complex [Ir(npy)2(dtubpy)](PF6) 
promoted a  red-shifted and structured emission coupled with a long-lived excited state that are 
indicative of a 3LC state (lPL = 590, 625 nm; FPL = 1%, tPL = 8.3 µs in MeCN).29 
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Figure 11. Computed spin densities in the lowest triplet state (B3LYP level, H atoms omitted 
for clarity, isodensity value 4.10-4 a.u.); two orientations are shown in each case, a side view 
(left of the labels) along the plane of the N^N ligand and a top view (right of the labels) down 
the axis of the mesityl rings of the C^N ligands. 
 
   Complex 6 exhibits the most red-shifted emission profile and is also the least emissive of the 
series. The spectrum is broad and noisy due to the low emission intensity of the complex. The 
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T1 state is assigned as a mixed 3LLCT and 3MLCT state, which is mirrored in the spin density 
calculations carried out on 6. The trend in the longest emission wavelengths parallels that of 
the computed vertical singlet-triplet splittings at the optimized structures of the triplets, 
although the resulting computed wavelengths (602 nm - 738 nm, see values in parentheses in 
the last column of Table S3) are largely overestimated with respect to experiment (527 nm - 
670 nm, Table 3). 
 
Complex 1 has a high FPL and short lifetime (FPL = 78%, tPL = 1.26 µs), which are in line 
with emission from a 3CT state. Complex 1 thus exhibits the highest radiative rate constant 
among 1–6 (kr = 6.19 × 105 s-1). The higher FPL of 1 compared to that reported for 
[Ir(ppy)2(H2bibenz)](PF6) (FPL = 33% in DCM)32 demonstrates the positive impact of the 
mesityl ring in inhibiting non-radiative decay processes. Alkylation with the o-xylene linker as 
in 2 results in an enhanced FPL and longer emission lifetime values (FPL = 89%, tPL = 1.83 
µs). The rigidified design has a clear effect in this instance as the non-radiative decay rate of 2 
(knr = 0.60 × 105 s-1) is suppressed by an order of magnitude compared to that of 1 (knr = 1.75 
× 105 s-1 for 2), despite competing with the energy gap law as a function of more red-shifted 
emission. As expected, similar radiative rate constant values for 1 and 2 (kr = 6.19 × 105 s-1 for 
1 and 4.89 × 105 s-1 for 2) show that this design feature impacts almost exclusively on non-
radiative quenching processes. When comparing to the known [Ir(Mesppy)2(dtbubpy)](PF6) 
(determined in MeCN),18c the emission was red-shifted, the excited state shorter-lived, and the 
FPL lower (lPL = 592 nm, tPL = 0.64 µs, FPL = 28%) in the known complex than for both 
complexes 1 and 2. Thus, this is evidence for the merits of employing the H2bibenz and o-
Xylbibenz ligands for achieving efficient emission in solution. 
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   When the Mesnpy C^N ligand is employed, two features become apparent: 1) the tPL values 
lengthen considerably as a consequence of the greater 3LC character of the T1 state; 2) the kr 
values for complexes 3–5 are an order of magnitude smaller than for the Mesppy complexes, 
which is the result of both the 3LC character in combination with the characteristic wavelength-
dependent reduction in radiative rates due to the energy gap law. For example, the lifetime of 
3 (tPL = 5.10 µs) is much longer than that of 1, but the FPL is lower (FPL = 32%) resulting from 
a lower radiative rate constant (kr = 0.63 × 105 s-1). These are classic features of 3LC states, 
which phosphoresce via indirect spin-orbit coupling pathways that are less quantum 
mechanically probable than the direct pathways by which 3CT states emit.35 The analogous 
comparison can be made between complexes 2 (FPL = 89%, tPL = 1.83 µs, kr = 4.86 × 105 s-1) 
and 4 (FPL = 44%, tPL = 7.65 µs, kr = 0.58 × 105 s-1). As with 1 vs 2, the merits of the xylylene 
bridge are evident, with a higher photoluminescence quantum yield observed for 4 versus 3. 
Complex 5 is much less emissive (FPL = 18%) than both complexes 3 and 4 due to a 
combination of a smaller radiative rate constant (kr = 0.27 × 105 s-1) and a larger non-radiative 
rate constant (knr = 1.03 × 105 s-1). Nevertheless, 5 has an enhanced FPL compared to 
[Ir(npy)2(dtbubpy)](PF6) (FPL = 1% in MeCN),29 illustrating the importance of the mesityl 
group in the Mesnpy C^N ligand towards inhibiting intermolecular quenching processes. Thus, 
the high FPL values measured for 2 and 4 are a result of the ligand scaffolds working in concert 
to inhibit both intramolecular quenching processes (o-Xylbibenz), and intermolecular 
quenching processes (Mesppy/Mesnpy). Gratifyingly, we have been able to demonstrate that 
these principles can be applied across the visible spectrum.  
 
To better elucidate the merits of employing our Mesnpy and o-Xylbibenz ligands in 
[Ir(C^N)2(N^N)]+ complexes, it is worth placing into context the photoluminescence quantum 
yield of 4 compared other cationic iridium(III) complexes with similar emission energies. We 
 29 
recently reported an exhaustive analysis of [Ir(C^N)2(N^N)]+ used in LEECs,6a and among 33 
complexes emitting in the orange-red (lPL > 599 nm) studied in this meta-analysis, only two 
had FPL values higher than 20%, with the vast majority of these emitting with 
photoluminescence quantum yields less than 5%. Of the two complexes emitting with high 
FPL, one complex, bearing a perylene diimide-functionalised (PDI) ancillary N^N ligand, emits 
with a higher photoluminescence quantum yield than seen for 4, but this was attributed to a 
fluorescence mechanism localised directly on the PDI group (lPL = 619 nm; FPL = 53%; tPL = 
3.0 ns in MeCN).36 The other complex was originally reported to emit with a FPL of 53%,37 
but this value has since been revised to only 25% (lPL = 620 nm; FPL = 25%; tPL = 0.39 µs in 
DCM).38 Thus, it is clear from this evidence that employing ligands systematically designed to 
suppress knr is a fruitful strategy for enhancing the quantum yield.  
 
Conclusions. 
Building on our previous studies focussed on the rational design of highly emissive blue/green 
emitters, the present study showcases the versatility of our molecular design principles to 
rationally design red-emitting iridium complexes with high quantum yields, using conjugated 
C^N ligands modified with bulky mesityl substituents in concert with rigidified 
bibenzimidazole N^N ancillary ligands. We have shown that the Mesppy complex 1 emits in 
the yellow/green (lPL = 500, 527 nm) but with higher quantum yield (FPL = 78%) than its 
previously reported mesityl-free analogue (FPL = 33%). Replacing the H2bibenz N^N ligand 
in 1 with the rigidified o-Xylbibenz ligand (2) red-shifts the emission (lPL = 560, 580 nm) and 
enhances the quantum yield further (FPL = 89%). Further red-shifting is possible when the 
more conjugated Mesnpy C^N is adopted (lPL = 585–626 nm for 3–5 and 670 nm for 6). 
Complexes 3–5 emit with virtually overlapping emission profiles, indicating emission from a 
similar excited state. However, mirroring 1 vs 2, both 3 (H2bibenz, FPL = 32%) and especially 
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5 (dtbubpy, FPL = 18%) are less emissive than 4 (o-Xylbibenz, FPL = 44%). Complex 6, with 
the biq N^N ligand, was found to be very poorly emissive. Comparing the quantum yield of 4 
with other red-emitters studied in LEECs places it in the top three most emissive complexes 
reported to date. The investigation of these complexes in LEECs is ongoing, with a particular 
focus on the crucial role of film morphology in devices, which still requires optimization to 
enhance the device performance. We expect these results to positively inform the future design 
of luminescent iridium complexes for a variety of applications, including light-emitting 
devices.  
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